Cardiac Energy Metabolism in Crotonaldehyde (Beta-methyl Acrolein) Exposed Male Wistar Rats

Physiology 2023 (Harrogate, UK) (2023) Proc Physiol Soc 54, PCB019

Poster Communications: Cardiac Energy Metabolism in Crotonaldehyde (Beta-methyl Acrolein) Exposed Male Wistar Rats

Olufemi Oluranti1, Abayomi Ige1, Bernard Adele1, Elsie Adewoye1,

1Bowen University, Iwo Iwo Nigeria, 2University of Ibadan Ibadan Nigeria,

View other abstracts by:


Introduction: Alterations in cardiac energy metabolic pathways arising from exposure to environmental pollutants have been linked to the development of cardiac dysfunction. Crotonaldehyde (CRO), a hazardous environmental pollutant, has been reported to be cardio-toxic.

 

Aim: However, dearth of information exists on the effect of CRO exposure on cardiac energy metabolism with respect to its cardio-toxicity. This study was therefore designed to investigate cardiac energy metabolism in male Wistar rats exposed to CRO.

 

Method: 36 male Wistar rats (150-170g; n=9) were grouped into 4 (I-IV): Control (10mL/kg normal-saline), CRO (0.75, 1.5, and 2.5mg/kg, p.o) for 28 days. Blood samples were obtained and evaluated for plasma Creatinine Kinase-Myocardial band (CK-Mb), cardiac troponin-I (cTnI), glucose, triglyceride, Free Fatty Acid (FFA) and insulin levels by spectrophotometry. Cardiac triglyceride, FFA, pyruvate, glucose-6-phosphate, cardiac hexokinase, pyruvate dehydrogenase (PDH) and nuclear factor erythroid-2 related-factor (Nrf2) activities were determined using ELISA. Cardiac malondialdehyde (MDA), hydrogen peroxide (H2O2), reduced glutathione (GSH) level, superoxide dismutase (SOD), and catalase activities were measured by spectrophotometry. Cardiac glucose transporter-4 (GLUT4), Peroxisome Proliferator-activated Receptor-alpha (PPARα), Carnitine Palmitoyl Transferase-1β (CPT1β) and AMP-activated Protein Kinase (AMPK) activities were determined immunohistochemically. Data were analysed using descriptive statistics and ANOVA at α0.05. This study complied with ethical standard and was approved by the University of Ibadan Animal Care and Use Research Ethics Committee (UI-ACUREC/18/007).

 

Results: Levels of CK-Mb, cTnI, glucose increased significantly while plasma and cardiac triglyceride, FFA, and insulin reduced significantly in all CRO-treated groups compared with control. Cardiac Pyruvate level, hexokinase and PDH activities increased significantly in all CRO-treated groups compared with control. Cardiac levels of MDA and H2O2 increased significantly while GSH and Nrf2 reduced; SOD and CAT activities decreased following CRO exposure compared with control. Cardiac GLUT4 (15.31 and 28.86 %) and PPARα (73.25, 102.79 %) expression increased in groups II and III, while CPT1β expression decreased in group II (66.46 %) but increased in groups III and IV (52.80 and 33.45 %) compared with control.

 

Conclusion: Crotonaldehyde exposure exerts cardio-toxic effects by altering cardiac energy metabolism resulting in reduced free fatty acid, increased glucose uptake and utilization; down-regulation of nuclear factor erythroid-2 related-factor and up-regulation of peroxisome proliferator-activated receptor-alpha.

 

Keywords:      Crotonaldehyde, energy metabolism, cardio-toxicity, redox imbalance



Where applicable, experiments conform with Society ethical requirements.

Site search

Filter

Content Type